Remembering visceral leishmaniasis as a potential trigger of haemophagocytic lymphohistiocytosis in individuals treated with anti-TNF-alpha therapy

Eur J Rheumatol. 2019 Aug 20;6(4):226-227. doi: 10.5152/eurjrheum.2019.18178. Print 2019 Oct.

Authors

Amina Nardo-Marino¹, Katrine Bukan^{1

2}, Henrik Vedel Nielsen³, Daniel El Fassi^{1

4}

Affiliations

¹ Department of Haematology, Herlev and Gentofte Hospital, Copenhagen University Hospital, Herlev, Denmark.
² Department of Nephrology, Herlev and Gentofte Hospital, Copenhagen University Hospital, Herlev, Denmark.
³ Department of Bacteria, Parasites and Fungi, Statens Serum Institut, Copenhagen, Denmark.
⁴ Department of Rheumatology, Rigshospitalet, Institute for Inflammation Research, Copenhagen University Hospital, Copenhagen, Denmark.

No abstract available

Publication types

Letter